首页 | 本学科首页   官方微博 | 高级检索  
     


Free radical production induced by methamphetamine in rat striatal synaptosomes
Authors:Pubill David  Chipana Carlos  Camins Antonio  Pallàs Mercè  Camarasa Jordi  Escubedo Elena
Affiliation:Unitat de Farmacologia i Farmacognòsia, Facultat de Farmàcia, Nucli Universitari de Pedralbes, Universitat de Barcelona, 08028 Barcelona, Spain. d.pubill@ub.edu
Abstract:The pro-oxidative effect of methamphetamine (METH) in dopamine terminals was studied in rat striatal synaptosomes. Flow cytometry analysis showed increased production of reactive oxygen species (ROS) in METH-treated synaptosomes, without reduction in the density of dopamine transporters. In synaptosomes from dopamine (DA)-depleted animals, METH did not induce ROS production. Reserpine, in vitro, completely inhibited METH-induced ROS production. These results point to endogenous DA as the main source of ROS induced by METH. Antioxidants and inhibitors of neuronal nitric oxide synthase and protein kinase C (PKC) prevented the METH-induced oxidative effect. EGTA and the specific antagonist methyllycaconitine (MLA, 50 microM) prevented METH-induced ROS production, thus implicating calcium and alpha7 nicotinic receptors in such effect. Higher concentrations of MLA (>100 microM) showed nonspecific antioxidant effect. Preincubation of synaptosomes with METH (1 microM) for 30 min reduced [(3)H]DA uptake by 0%. The METH effect was attenuated by MLA and EGTA and potentiated by nicotine, indicating that activation of alpha(7) nicotinic receptors and Ca(2+) entry are necessary and take place before DAT inhibition. From these findings, it can be postulated that, in our model, METH induces DA release from synaptic vesicles to the cytosol. Simultaneously, METH activates alpha(7) nicotinic receptors, probably inducing depolarization and an increase in intrasynaptosomal Ca(2+). This would lead to DAT inhibition and NOS and PKC activation, initiating oxidation of cytosolic DA.
Keywords:AMPT, α-methyl-p-tyrosine   DA, dopamine   DAT, dopamine transporter   DBE, dihydro-β-erythroidine   DCFH-DA, 2′,7′-dichlorofluorescin diacetate   DCF, 2′,7′-dichlorofluorescein   EGTA, ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid   5-HT, serotonin   MDMA, methylenedioxymethamphetamine   METH, methamphetamine   MLA, methyllycaconitine   NBQX, 1,2,3,4-tetrahydro-6-nitro-2,3-dioxo-benzo[f]quinoxaline-7-sulfonamide   7-NI, 7-nitroindazole   nNOS, neuronal nitric oxide synthase   NPC 15437, (S)-2,6-Diamino-N-[(1-(1-oxotridecyl)-2-piperidinyl)methyl]hexanamide dihydrochloride   PCP, phencyclidine   PKC, protein kinase C   ROS, reactive oxygen species   SERT, serotonin transporter   VMAT, vesicular monoamine transporter
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号